Filings/MAB/IR

MABION S.A. IR

press release · 2026-08-26

MabionCD20 – FDA grants type B pre-IND meeting in just 14 days 26.08.2026

Source document

Issuer site
Loading document…
MabionCD20 – FDA grants type B pre-IND meeting in just 14 days 26.08.2026 — MABION S.A.